You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

Article metrics

Article menu

Download PDFPDF

Letter
Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

 

Online download statistics by month:

Online download statistics by month: March 2023 to March 2024

AbstractFullPdf
Mar 2023030173
Apr 2023011819
May 2023010717
Jun 20230819
Jul 202306214
Aug 2023011615
Sep 202307110
Oct 202308317
Nov 202305713
Dec 202304112
Jan 202404011
Feb 202403316
Mar 202405040
Total01160266